TGF-β receptor function in the endothelium

Cardiovascular Research

Volumn 65, Issue 3, 2005, Pages 599-608

  Lebrin, Franck ^a   Deckers, Martine ^a   Bertolino, Philippe ^a   Ten Dijke, Peter ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Angiogenesis; Hereditary Haemorrhagic Telangiectasia; Smad; TGF

Indexed keywords

ENDOGLIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; AUTOSOMAL DOMINANT DISORDER; CELL MIGRATION; CELL PROLIFERATION; EXPERIMENTAL MOUSE; GENE MUTATION; HUMAN; MOLECULAR BIOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; REVIEW; SIGNAL TRANSDUCTION; VASCULAR PATENCY;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 12344273467     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.10.036     Document Type: Review

References (98)

1. A.B. Roberts, and M.B. Sporn Physiological actions and clinical applications of transforming growth factor-β (TGF-β) Growth Factors 8 1993 1 9
2. P. ten Dijke, and C.S. Hill New insights into TGF-β-Smad signalling Trends Biochem. Sci. 29 2004 265 273
3. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-β family signalling Nature 425 2003 577 584
4. M.-J. Goumans, G. Valdimarsdottir, S. Itoh, A. Rosendahl, P. Sideras, and P. ten Dijke Balancing the activation state of the endothelium via two distinct TGF-β type I receptors EMBO J. 21 2002 1743 1753
5. M.-J. Goumans, and C. Mummery Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice Int. J. Dev. Biol. 44 2000 253 265
6. M.S. Pepper Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev. 8 1997 21 43
7. M.-J. Goumans, F. Lebrin, and G. Valdimarsdottir Controlling the angiogenic switch: a balance between two distinct TGF-β receptor signaling pathways Trends Cardiovasc. Med. 13 2003 301 307
8. J. Massagué, S.W. Blain, and R.S. Lo TGFβ signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
9. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor β in human disease N. Engl. J. Med. 342 2000 1350 1358
10. R. Derynck, R.J. Akhurst, and A. Balmain TGF-β signaling in tumor suppression and cancer progression Nat. Genet. 29 2001 117 129
11. A.B. Roberts, and L.M. Wakefield The two faces of transforming growth factor β in carcinogenesis Proc. Natl. Acad. Sci. U. S. A. 100 2003 8621 8623
12. D.W. Johnson, J.N. Berg, M.A. Baldwin, C.J. Gallione, I. Marondel, and S.J. Yoon Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 Nat. Genet. 13 1996 189 195
13. K.A. McAllister, K.M. Grogg, D.W. Johnson, C.J. Gallione, M.A. Baldwin, and C.E. Jackson Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 Nat. Genet. 8 1994 345 351
14. J.L. Wrana, L. Attisano, R. Wieser, F. Ventura, and J. Massagué Mechanism of activation of the TGF-β receptor Nature 370 1994 341 347
15. R. Wieser, J.L. Wrana, and J. Massagué GS domain mutations that constitutively activate T βR-I, the downstream signaling component in the TGF-β receptor complex EMBO J. 14 1995 2199 2208
16. K. Luo, and H.F. Lodish Signaling by chimeric erythropoietin-TGF-β receptors: homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction EMBO J. 15 1996 4485 4496
17. F. Weis-Garcia, and J. Massagué Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling EMBO J. 15 1996 276 289
18. H. Yamashita, P. ten Dijke, P. Franzén, K. Miyazono, and C.-H. Heldin Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β J. Biol. Chem. 269 1994 20172 20178
19. S. Abdollah, M. Macias-Silva, T. Tsukazaki, H. Hayashi, L. Attisano, and J.L. Wrana TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling J. Biol. Chem. 272 1997 27678 27685
20. A. Nakao, T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, and E. Oeda TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4 EMBO J. 16 1997 5353 5362
21. G. Lagna, A. Hata, A. Hemmati-Brivanlou, and J. Massagué Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways Nature 383 1996 832 836
22. T. Imamura, M. Takase, A. Nishihara, E. Oeda, J. Hanai, and M. Kawabata Smad6 inhibits signalling by the TGF-β superfamily Nature 389 1997 622 626
23. A. Nakao, M. Afrakhte, A. Morén, T. Nakayama, J.L. Christian, and R. Heuchel Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling Nature 389 1997 631 635
24. P. Kavsak, R.K. Rasmussen, C.G. Causing, S. Bonni, H. Zhu, and G.H. Thomsen Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation Mol. Cell 6 2000 1365 1375
25. C. Suzuki, G. Murakami, M. Fukuchi, T. Shimanuki, Y. Shikauchi, and T. Imamura Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane J. Biol. Chem. 277 2002 39919 39925
26. W. Shi, C. Sun, B. He, W. Xiong, X. Shi, and D. Yao GADD34-PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor J. Cell Biol. 164 2004 291 300
27. J.N. Topper, J. Cai, Y. Qiu, K.R. Anderson, Y.Y. Xu, and J.D. Deeds Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium Proc. Natl. Acad. Sci. U. S. A. 94 1997 9314 9319
28. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
29. K.K. Hirschi, S.A. Rohovsky, and P.A. D'Amore PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate J. Cell Biol. 141 1998 805 814
30. D.C. Darland, L.J. Massingham, S.R. Smith, E. Piek, M. Saint-Geniez, and P.A. D'Amore Pericyte production of cell-associated VEGF is differentiation- dependent and is associated with endothelial survival Dev. Biol. 264 2003 275 288
31. M.C. Dickson, J.S. Martin, F.M. Cousins, A.B. Kulkarni, S. Karlsson, and R.J. Akhurst Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice Development 121 1995 1845 1854
32. U. Bartram, D.G. Molin, L.J. Wisse, A. Mohamad, L.P. Sanford, and T. Doetschman Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-β2-knockout mice Circulation 103 2001 2745 2752
33. L.P. Sanford, I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, and G.P. Boivin TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes Development 124 1997 2659 2670
34. M. Oshima, H. Oshima, and M.M. Taketo TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis Dev. Biol. 179 1996 297 302
35. J. Larsson, M.-J. Goumans, L.J. Sjostrand, M.A. van Rooijen, D. Ward, and P. Leveen Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice EMBO J. 20 2001 1663 1673
36. S.P. Oh, T. Seki, K.A. Goss, T. Imamura, Y. Yi, and P.K. Donahoe Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis Proc. Natl. Acad. Sci. U. S. A. 97 2000 2626 2631
37. K.D. Tremblay, N.R. Dunn, and E.J. Robertson Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation Development 128 2001 3609 3621
38. R.J. Lechleider, J.L. Ryan, L. Garrett, C. Eng, C. Deng, and A. Wynshaw-Boris Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion Dev. Biol. 240 2001 157 167
39. H. Chang, D. Huylebroeck, K. Verschueren, Q. Guo, M.M. Matzuk, and A. Zwijsen Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects Development 126 1999 1631 1642
40. X. Yang, L.H. Castilla, X. Xu, C. Li, J. Gotay, and M. Weinstein Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5 Development 126 1999 1571 1580
41. D.Y. Li, L.K. Sorensen, B.S. Brooke, L.D. Urness, E.C. Davis, and D.G. Taylor Defective angiogenesis in mice lacking endoglin Science 284 1999 1534 1537
42. H.M. Arthur, J. Ure, A.J. Smith, G. Renforth, D.I. Wilson, and E. Torsney Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development Dev. Biol. 217 2000 42 53
43. A. Bourdeau, D.J. Dumont, and M. Letarte A murine model of hereditary hemorrhagic telangiectasia J. Clin. Invest. 104 1999 1343 1351
44. K.L. Stenvers, M.L. Tursky, K.W. Harder, N. Kountouri, S. Amatayakul-Chantler, and D. Grail Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos Mol. Cell. Biol. 23 2003 4371 4385
45. T. Ota, M. Fujii, T. Sugizaki, M. Ishii, K. Miyazawa, and H. Aburatani Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-β in human umbilical vein endothelial cells J. Cell. Physiol. 193 2002 299 318
46. S. Stefansson, and D.A. Lawrence The serpin PAI-1 inhibits cell migration by blocking integrin αVβ3 binding to vitronectin Nature 383 1996 441 443
47. S. Stefansson, E. Petitclerc, M.K. Wong, G.A. McMahon, P.C. Brooks, and D.A. Lawrence Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1 J. Biol. Chem. 276 2001 8135 8141
48. T. Watabe, A. Nishihara, K. Mishima, J. Yamashita, K. Shimizu, and K. Miyazawa TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells J. Cell Biol. 163 2003 1303 1311
49. S. Lamouille, C. Mallet, J.J. Feige, and S. Bailly Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis Blood 100 2002 4495 4501
50. B.L. Roman, V.N. Pham, N.D. Lawson, M. Kulik, S. Childs, and A.C. Lekven Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels Development 129 2002 3009 3019
51. M.J. Goumans, G. Valdimarsdottir, S. Itoh, F. Lebrin, J. Larsson, and C. Mummery Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling Mol. Cell 12 2003 817 828
52. I. Mucsi, K.L. Skorecki, and H.J. Goldberg Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-β1 on gene expression J. Biol. Chem. 271 1996 16567 16572
53. S. Edlund, M. Landstrom, C.-H. Heldin, and P. Aspenstrom Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA Mol. Biol. Cell 13 2002 902 914
54. P.L. Goldberg, D.E. MacNaughton, R.T. Clements, F.L. Minnear, and P.A. Vincent p38 MAPK activation by TGF-β1 increases MLC phosphorylation and endothelial monolayer permeability Am. J. Physiol. Lung Cell. Mol. Physiol. 282 2002 L146 L154
55. F. Vinals, and J. Pouyssegur Transforming growth factor β1 (TGF-β1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-α signaling Mol. Cell. Biol. 21 2001 7218 7230
56. J.R. Merwin, W. Newman, L.D. Beall, A. Tucker, and J. Madri Vascular cells respond differentially to transforming growth factors β1 and β2 in vitro Am. J. Pathol. 138 1991 37 51
57. S. Sankar, N. Mahooti-Brooks, M. Centrella, T.L. McCarthy, and J.A. Madri Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor β2 J. Biol. Chem. 270 1995 13567 13572
58. S. Cheifetz, H. Hernandez, M. Laiho, P. ten Dijke, K.K. Iwata, and J. Massagué Distinct transforming growth factor-β (TGF-β) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms J. Biol. Chem. 265 1990 20533 20538
59. W. Chen, K.C. Kirkbride, T. How, C.D. Nelson, J. Mo, and J.P. Frederick β-arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling Science 301 2003 1394 1397
60. S. Cheifetz, T. Bellon, C. Cales, S. Vera, C. Bernabeu, and J. Massagué Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells J. Biol. Chem. 267 1992 19027 19030
61. N.P. Barbara, J.L. Wrana, and M. Letarte Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-β superfamily J. Biol. Chem. 274 1999 584 594
62. A. Letamendia, P. Lastres, L.M. Botella, U. Raab, C. Langa, and B. Velasco Role of endoglin in cellular responses to transforming growth factor-β. A comparative study with betaglycan J. Biol. Chem. 273 1998 33011 33019
63. M. Guerrero-Esteo, T. Sanchez-Elsner, A. Letamendia, and C. Bernabeu Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-β receptors I and II J. Biol. Chem. 277 2002 29197 29209
64. P. Lastres, A. Letamendia, H. Zhang, C. Rius, N. Almendro, and U. Raab Endoglin modulates cellular responses to TGF-β1 J. Cell Biol. 133 1996 1109 1121
65. J. Obreo, L. Diez-Marques, S. Lamas, A. Duwell, N. Eleno, and C. Bernabeu Endoglin expression regulates basal and TGF-β1-induced extracellular matrix synthesis in cultured L(6)E(9) myoblasts Cell. Physiol. Biochem. 14 2004 301 310
66. M. Quintanilla, J.R. Ramirez, E. Perez-Gomez, D. Romero, B. Velasco, and M. Letarte Expression of the TGF-β coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis Oncogene 22 2003 5976 5985
67. C. Li, I.N. Hampson, L. Hampson, P. Kumar, C. Bernabeu, and S. Kumar CD105 antagonizes the inhibitory signaling of transforming growth factor β1 on human vascular endothelial cells FASEB J. 14 2000 55 64
68. X. She, F. Matsuno, N. Harada, H. Tsai, and B.K. Seon Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-β in suppression of growth of human endothelial cells Int. J. Cancer 108 2004 251 257
69. B. Guo, M. Slevin, C. Li, S. Parameshwar, D. Liu, and P. Kumar CD105 inhibits transforming growth factor-β-Smad3 signalling Anticancer Res. 24 2004 1337 1345
70. A. Gougos, and M. Letarte Biochemical characterization of the 44G4 antigen from the HOON pre-B leukemic cell line J. Immunol. 141 1988 1934 1940
71. S.E. Duff, C. Li, J.M. Garland, and S. Kumar CD105 is important for angiogenesis: evidence and potential applications FASEB J. 17 2003 984 992
72. C.Z. Chen, M. Li, D. de Graaf, S. Monti, B. Gottgens, and M.J. Sanchez Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 15468 15473
73. T. Sanchez-Elsner, L.M. Botella, B. Velasco, C. Langa, and C. Bernabeu Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-β pathways J. Biol. Chem. 277 2002 43799 43808
74. D.W. Miller, W. Graulich, B. Karges, S. Stahl, M. Ernst, and A. Ramaswamy Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumor endothelial cells Int. J. Cancer 81 1999 568 572
75. E. Fonsatti, M. Altomonte, M.R. Nicotra, P.G. Natali, and M. Maio Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels Oncogene 22 2003 6557 6563
76. C. Li, B. Guo, S. Ding, C. Rius, C. Langa, and P. Kumar TNFα down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGFβ1 Anticancer Res. 23 2003 1189 1196
77. F. Lebrin, M.-J. Goumans, L. Jonker, R.L.C. Carvalho, G. Valdimarsdottir, and M. Thorikay Endoglin promotes endothelial cell proliferation and TGFβ/ALK1 signal transduction EMBO J. 23 2004 4018 4028
78. M.E. Paquet, N. Pece-Barbara, S. Vera, U. Cymerman, A. Karabegovic, and C. Shovlin Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function Hum. Mol. Genet. 10 2001 1347 1357
79. N. Pece-Barbara, U. Cymerman, S. Vera, D.A. Marchuk, and M. Letarte Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1 Hum. Mol. Genet. 8 1999 2171 2181
80. N. Pece, S. Vera, U. Cymerman, R.I. White Jr., J.L. Wrana, and M. Letarte Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative J. Clin. Invest. 100 1997 2568 2579
81. J.N. Berg, C.J. Gallione, T.T. Stenzel, D.W. Johnson, W.P. Allen, and C.E. Schwartz The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2 Am. J. Hum. Genet. 61 1997 60 67
82. S.A. Abdalla, N. Pece-Barbara, S. Vera, E. Tapia, E. Paez, and C. Bernabeu Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2 Hum. Mol. Genet. 9 2000 1227 1237
83. C.L. Shovlin Supermodels and disease: insights from the HHT mice J. Clin. Invest. 104 1999 1335 1336
84. F. Sanz-Rodriguez, A. Fernandez-Lopez, R. Zarrabeitia, A. Perez-Molino, J.R. Ramirez, and E. Coto Mutation analysis in spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes Clin. Chem. 50 2004 2003 2011
85. A. Bourdeau, M.E. Faughnan, and M. Letarte Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia Trends Cardiovasc. Med. 10 2000 279 285
86. E. Torsney, R. Charlton, A.G. Diamond, J. Burn, J.V. Soames, and H.M. Arthur Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality Circulation 107 2003 1653 1657
87. G.M. Wallace, and C.L. Shovlin A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1 Thorax 55 2000 685 690
88. M. Piantanida, E. Buscarini, C. Dellavecchia, A. Minelli, A. Rossi, and L. Buscarini Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2 J. Med. Genet. 33 1996 441 443
89. E. Buscarini, L. Buscarini, C. Danesino, M. Piantanida, G. Civardi, and P. Quaretti Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family J. Hepatol. 26 1997 111 118
90. C.J. Gallione, G.M. Repetto, E. Legius, A.K. Rustgi, S.L. Schelley, and S. Tejpar A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4) Lancet 363 2004 852 859
91. B. Xu, Y.Q. Wu, M. Huey, H.M. Arthur, D.A. Marchuk, and T. Hashimoto Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain J. Cereb. Blood Flow Metab. 24 2004 237 244
92. C. Li, R. Issa, P. Kumar, I.N. Hampson, J.M. Lopez-Novoa, and C. Bernabeu CD105 prevents apoptosis in hypoxic endothelial cells J. Cell Sci. 116 2003 2677 2685
93. B.A. Conley, R. Koleva, J.D. Smith, D. Kacer, D. Zhang, and C. Bernabeu Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain J. Biol. Chem. 279 2004 27440 27449
94. F. Sanz-Rodriguez, M. Guerrero-Esteo, L.M. Botella, D. Banville, C.P. Vary, and C. Bernabeu Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins J. Biol. Chem. 279 2004 32858 32868
95. M. Jerkic, J.V. Rivas-Elena, M. Prieto, R. Carron, F. Sanz-Rodriguez, and F. Perez-Barriocanal Endoglin regulates nitric oxide-dependent vasodilatation FASEB J. 18 2004 609 611
96. R.L.C. Carvalho, L. Jonker, M.-J. Goumans, J. Larsson, P. Bouwman, and S. Karlsson Defective paracrine signalling by TGFβ in yolk sac vasculature of endoglin mutant mice: a paradigm for Hereditary Hemorrhagic Telangiectasia Development 2004 [in press]
97. T. Seki, K.H. Hong, J. Yun, S.J. Kim, and S.P. Oh Isolation of a regulatory region of activin receptor-like kinase 1 gene sufficient for arterial endothelium-specific expression Circ. Res. 94 2004 e72 e77
98. K. Miyazono, P. ten Dijke, H. Ichijo, and C.-H. Heldin Receptors for transforming growth factor-β F.J. Dixon Advances in Immunology vol. 55 1994 181 220